Results 261 to 270 of about 433,923 (290)

Pancreatic Ductal Adenocarcinoma

2018
Objective: Patients who undergo an R0 resection of their pancreatic ductal adenocarcinoma (PDAC) have an improved survival compared with patients who undergo an R1 resection. It is unclear whether an R1 resection confers a survival benefit over locally advanced (LA) unresectable tumors.
Konstantinidis, Ioannis T, Warshaw, Andrew, Allen, Jill, Blaszkowsky, Lawrence, Castillo, Carlos, Deshpande, Vikram, Hong, Theodore, Kwak, Eunice Lee, Lauwers, Gregory Y., Ryan, David, Wargo, Jennifer Ann, Lillemoe, Keith, Ferrone, Cristina   +12 more
openaire   +4 more sources

Pancreatic Resection for M1 Pancreatic Ductal Adenocarcinoma

Annals of Surgical Oncology, 2006
Improved safety of pancreatic surgery has led to consideration of more aggressive approaches, such as resection for primary pancreatic ductal adenocarcinoma (PDAC) with metastatic disease (M1).A total of 29 patients who underwent pancreatic resection with resection of associated metastatic disease (interaortocaval lymph node dissection, liver resection,
Shailesh V, Shrikhande, Jörg, Kleeff, Carolin, Reiser, Jürgen, Weitz, Ulf, Hinz, Irene, Esposito, Jan, Schmidt, Helmut, Friess, Markus W, Büchler   +8 more
openaire   +2 more sources

Pancreatic Ductal Adenocarcinoma Derived From IPMN and Pancreatic Ductal Adenocarcinoma Concomitant With IPMN

Pancreas, 2011
Pancreatic ductal adenocarcinoma (PDAC) may derive from an intraductal papillary mucinous neoplasm (IPMN) of the pancreas or may develop in the pancreatic duct apart from IPMN. The purpose of this study was to define the clinicopathological features of these 2 entities and compare them with those of ordinary PDAC.Of 765 patients who had surgical ...
Koji, Yamaguchi, Shuichi, Kanemitsu, Takashi, Hatori, Hiroyuki, Maguchi, Yasuhiro, Shimizu, Minoru, Tada, Toshio, Nakagohri, Keiji, Hanada, Manabu, Osanai, Yutaka, Noda, Akihiko, Nakaizumi, Toru, Furukawa, Shinichi, Ban, Bunsei, Nobukawa, Yo, Kato, Masao, Tanaka   +15 more
openaire   +2 more sources

Proteogenomic characterization of pancreatic ductal adenocarcinoma

Cell, 2021
Christopher R Kinsinger, Ana I Robles, David Fenyo   +2 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Diane M Simeone, Colin Weekes, Anirban Maitra   +2 more
exaly  

Pancreatic Ductal Adenocarcinoma

2023
Anushri Parakh, Yoshifumi Noda, Avinash R. Kambadakone, Dushant V. Sahani   +3 more
openaire   +1 more source

Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects

Chronic Diseases and Translational Medicine, 2020
Nan Niu, Keyu Li, Lei Zheng
exaly  

Tumor-Node-Metastasis Staging of Pancreatic Adenocarcinoma†

Ca-A Cancer Journal for Clinicians, 2008
Douglas B Evans, Jason Fleming, Matthew H G Katz   +2 more
exaly  

The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma

Clinical Gastroenterology and Hepatology, 2008
Irene Esposito, Mert Erkan
exaly  

Pancreatic Ductal Adenocarcinoma

2004
Michael Bouvet, Jeannie Shen, A.R. Moossa   +2 more
openaire   +1 more source